Brief: Acerus Buys Back All Remaining U.S. Rights For Natesto From Aytu

Aytu Biopharma

01/04/2021 12:35

April 1 (Reuters) - Acerus Pharmaceuticals Corporation
 ASP.TO :
    * ACERUS BUYS BACK ALL REMAINING U.S. RIGHTS FOR NATESTO®
FROM
AYTU
    * ACERUS PHARMACEUTICALS - ACERUS HAS AGREED TO PURCHASE
RIGHTS
FROM AYTU FOR $7.5 MILLION USD, PAID EVENLY OVER 30 MONTHLY
INSTALLMENTS
    * ACERUS PHARMACEUTICALS - ACERUS EXPECTS PAYMENTS TO BE
FUNDED
FROM NET REVENUES GENERATED BY NATESTO
    * ACERUS PHARMACEUTICALS - AYTU WILL CONTINUE TO PROVIDE
DISTRIBUTION OF NATESTO UNDER TERMS OF EXISTING LICENSE AND
SUPPLY AGREEMENT

Source text for Eikon:  ID:nGNX246JLf 
Further company coverage:  ASP.TO 

 ((Reuters.Briefs@thomsonreuters.com;))